Cargando…

Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder

IMPORTANCE: Buprenorphine treatment for opioid use disorder (OUD) is associated with decreased morbidity and mortality. Despite its effectiveness, buprenorphine uptake has been limited relative to the burden of OUD. Prior authorization (PA) policies may present a barrier to treatment, though researc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christine, Paul J., Larochelle, Marc R., Lin, Lewei (Allison), McBride, Jonathon, Tipirneni, Renuka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589810/ https://www.ncbi.nlm.nih.gov/pubmed/37862034 http://dx.doi.org/10.1001/jamahealthforum.2023.3549

Ejemplares similares

Thematic Analysis of State Medicaid Buprenorphine Prior Authorization Requirements
por: Nguemeni Tiako, Max Jordan, et al.
Publicado: (2023)

Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs
por: Keshwani, Shailina, et al.
Publicado: (2022)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance
por: Jeffery, Molly Moore, et al.
Publicado: (2020)

Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic
por: Frost, Madeline C., et al.
Publicado: (2022)

Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion
por: Saloner, Brendan, et al.
Publicado: (2018)

Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care
por: Abraham, Amanda J., et al.
Publicado: (2022)

Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids
por: Lagisetty, Pooja A., et al.
Publicado: (2019)

Association of Access to Family Planning Services With Medicaid Expansion Among Female Enrollees in Michigan
por: Moniz, Michelle H., et al.
Publicado: (2018)

Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine
por: Nguemeni Tiako, Max Jordan, et al.
Publicado: (2020)

Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries
por: Mark, Tami L., et al.
Publicado: (2020)

Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021
por: Nguyen, Thuy D., et al.
Publicado: (2022)

Association of Medicaid Expansion With Enrollee Employment and Student Status in Michigan
por: Tipirneni, Renuka, et al.
Publicado: (2020)

Health Navigator Perspectives on Implementation of Healthy Michigan Plan Work Requirements
por: Kelly, R. Patrick, et al.
Publicado: (2022)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022)

Examination of Changes in Health Status Among Michigan Medicaid Expansion Enrollees From 2016 to 2017
por: Patel, Minal R., et al.
Publicado: (2020)

Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder
por: Haffajee, Rebecca L., et al.
Publicado: (2019)

Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
por: D’Onofrio, Gail, et al.
Publicado: (2023)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)

Lower buprenorphine elimination rate constant is associated with lower opioid use
por: Elarabi, Hesham Farouk, et al.
Publicado: (2022)

Opioid replacement therapy with methadone or buprenorphine effects on male mice reproduction
por: Moinaddini, Fatemeh, et al.
Publicado: (2022)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Health Policy Perspective: Medicaid and State Politics Beyond COVID
por: Zhu, Jane M., et al.
Publicado: (2020)

Buprenorphine Utilization and Prescribing Among New Jersey Medicaid Beneficiaries After Adoption of Initiatives Designed to Improve Treatment Access
por: Treitler, Peter, et al.
Publicado: (2023)

Association of Medicaid Expansion With Opioid Overdose Mortality in the United States
por: Kravitz-Wirtz, Nicole, et al.
Publicado: (2020)

High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
por: Herring, Andrew A., et al.
Publicado: (2021)

Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
por: Tanz, Lauren J., et al.
Publicado: (2023)

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021)

Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use
por: Xu, Kevin Y., et al.
Publicado: (2022)

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl
por: Chambers, Laura C., et al.
Publicado: (2023)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy
por: Larochelle, Marc R., et al.
Publicado: (2022)

Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
por: Mikosz, Christina A., et al.
Publicado: (2020)

Association of Social and Demographic Factors With COVID-19 Incidence and Death Rates in the US
por: Karmakar, Monita, et al.
Publicado: (2021)

Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017
por: Tori, Marco E., et al.
Publicado: (2020)

Assessment of Medicaid Beneficiaries Included in Community Engagement Requirements in Kentucky
por: Venkataramani, Atheendar S., et al.
Publicado: (2019)

Public Views on Medicaid Work Requirements and Mandatory Premiums in Kentucky
por: Underhill, Kristen, et al.
Publicado: (2023)

Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders
por: Clark, Brinton, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r2au57o05dsnc410hf9coe7sq1